0000065759 false 11/30 2022 Q2 0000065759 2021-12-01 2022-05-28 0000065759 2022-07-12 0000065759 2022-05-28 0000065759 2021-11-30 0000065759 2022-02-27 2022-05-28 0000065759 2021-02-28 2021-05-29 0000065759 2020-12-01 2021-05-29 0000065759 2020-11-30 0000065759 2021-05-29 0000065759 us-gaap:CommonStockMember 2020-11-30 0000065759 us-gaap:AdditionalPaidInCapitalMember 2020-11-30 0000065759 us-gaap:TreasuryStockMember 2020-11-30 0000065759 us-gaap:RetainedEarningsMember 2020-11-30 0000065759 us-gaap:CommonStockMember 2021-02-27 0000065759 us-gaap:AdditionalPaidInCapitalMember 2021-02-27 0000065759 us-gaap:TreasuryStockMember 2021-02-27 0000065759 us-gaap:RetainedEarningsMember 2021-02-27 0000065759 2021-02-27 0000065759 us-gaap:CommonStockMember 2021-11-30 0000065759 us-gaap:AdditionalPaidInCapitalMember 2021-11-30 0000065759 us-gaap:TreasuryStockMember 2021-11-30 0000065759 us-gaap:RetainedEarningsMember 2021-11-30 0000065759 us-gaap:CommonStockMember 2022-02-26 0000065759 us-gaap:AdditionalPaidInCapitalMember 2022-02-26 0000065759 us-gaap:TreasuryStockMember 2022-02-26 0000065759 us-gaap:RetainedEarningsMember 2022-02-26 0000065759 2022-02-26 0000065759 us-gaap:CommonStockMember 2020-12-01 2021-02-27 0000065759 us-gaap:AdditionalPaidInCapitalMember 2020-12-01 2021-02-27 0000065759 us-gaap:TreasuryStockMember 2020-12-01 2021-02-27 0000065759 us-gaap:RetainedEarningsMember 2020-12-01 2021-02-27 0000065759 2020-12-01 2021-02-27 0000065759 us-gaap:CommonStockMember 2021-02-28 2021-05-29 0000065759 us-gaap:AdditionalPaidInCapitalMember 2021-02-28 2021-05-29 0000065759 us-gaap:TreasuryStockMember 2021-02-28 2021-05-29 0000065759 us-gaap:RetainedEarningsMember 2021-02-28 2021-05-29 0000065759 us-gaap:CommonStockMember 2021-12-01 2022-02-26 0000065759 us-gaap:AdditionalPaidInCapitalMember 2021-12-01 2022-02-26 0000065759 us-gaap:TreasuryStockMember 2021-12-01 2022-02-26 0000065759 us-gaap:RetainedEarningsMember 2021-12-01 2022-02-26 0000065759 2021-12-01 2022-02-26 0000065759 us-gaap:CommonStockMember 2022-02-27 2022-05-28 0000065759 us-gaap:AdditionalPaidInCapitalMember 2022-02-27 2022-05-28 0000065759 us-gaap:TreasuryStockMember 2022-02-27 2022-05-28 0000065759 us-gaap:RetainedEarningsMember 2022-02-27 2022-05-28 0000065759 us-gaap:CommonStockMember 2021-05-29 0000065759 us-gaap:AdditionalPaidInCapitalMember 2021-05-29 0000065759 us-gaap:TreasuryStockMember 2021-05-29 0000065759 us-gaap:RetainedEarningsMember 2021-05-29 0000065759 us-gaap:CommonStockMember 2022-05-28 0000065759 us-gaap:AdditionalPaidInCapitalMember 2022-05-28 0000065759 us-gaap:TreasuryStockMember 2022-05-28 0000065759 us-gaap:RetainedEarningsMember 2022-05-28 0000065759 MPAD:MilitaryMember 2022-02-27 2022-05-28 0000065759 MPAD:SpaceMember 2022-02-27 2022-05-28 0000065759 MPAD:MedicalMember 2022-02-27 2022-05-28 0000065759 MPAD:CommercialMember 2022-02-27 2022-05-28 0000065759 MPAD:MilitaryMember 2021-02-28 2021-05-29 0000065759 MPAD:SpaceMember 2021-02-28 2021-05-29 0000065759 MPAD:MedicalMember 2021-02-28 2021-05-29 0000065759 MPAD:CommercialMember 2021-02-28 2021-05-29 0000065759 MPAD:MilitaryMember 2021-12-01 2022-05-28 0000065759 MPAD:SpaceMember 2021-12-01 2022-05-28 0000065759 MPAD:MedicalMember 2021-12-01 2022-05-28 0000065759 MPAD:CommercialMember 2021-12-01 2022-05-28 0000065759 MPAD:MilitaryMember 2020-12-01 2021-05-29 0000065759 MPAD:SpaceMember 2020-12-01 2021-05-29 0000065759 MPAD:MedicalMember 2020-12-01 2021-05-29 0000065759 MPAD:CommercialMember 2020-12-01 2021-05-29 0000065759 2020-12-01 0000065759 srt:MinimumMember us-gaap:BuildingMember 2021-12-01 2022-05-28 0000065759 srt:MaximumMember us-gaap:BuildingMember 2021-12-01 2022-05-28 0000065759 srt:MinimumMember MPAD:FacilityImprovementsMember 2021-12-01 2022-05-28 0000065759 srt:MaximumMember MPAD:FacilityImprovementsMember 2021-12-01 2022-05-28 0000065759 srt:MinimumMember MPAD:MachineryEquipmentMember 2021-12-01 2022-05-28 0000065759 srt:MaximumMember MPAD:MachineryEquipmentMember 2021-12-01 2022-05-28 0000065759 srt:MinimumMember MPAD:FurnitureFixturesMember 2021-12-01 2022-05-28 0000065759 srt:MaximumMember MPAD:FurnitureFixturesMember 2021-12-01 2022-05-28 0000065759 MPAD:ConstructionLoanAgreementMember 2021-03-26 0000065759 2021-03-26 0000065759 MPAD:RevolvingLoanMember 2021-03-26 0000065759 MPAD:DividendMember 2020-12-01 2021-05-29 0000065759 MPAD:DividendMember 2021-12-01 2022-05-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure
 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

     
  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended May 28, 2022

OR

     
  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number 0-5109

 

MICROPAC INDUSTRIES, INC.

  

 

Delaware   75-1225149
(State or other jurisdiction of incorporation or organization)   (I.R.S. Employer Identification No.)
     

 

905 E. Walnut, Garland, Texas

  75040
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, including Area Code: (972) 272-3571

 

Securities Registered Pursuant to Section 12(g) of the Act:

 

Title of each class Trading
Symbol(s)
  Name of each exchange on which registered
Common Stock, $0.10 par value per share MPAD  NONE

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of large accelerated filer,” accelerated filer,” smaller reporting company,” and emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Emerging growth company

Accelerated filer ☐

Non-accelerated filer

Smaller reporting company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

On July 12, 2022, there were 2,578,315 shares of Common Stock, $0.10 par value, outstanding.

 
1 
 

 

MICROPAC INDUSTRIES, INC.

 

FORM 10-Q

 

May 28, 2022

 

INDEX

 

PART I - FINANCIAL INFORMATION

 

ITEM 1 - FINANCIAL STATEMENTS

 

Condensed Balance Sheets as of May 28, 2022 (unaudited) and November 30, 2021

Condensed Statements of Operations for the three and six months ended May 28, 2022 and May 29, 2021 (unaudited)

Condensed Statements of Cash Flows for the six months ended May 28, 2022 and May 29, 2021 (unaudited)

Condensed Statements of Shareholders’ Equity for the three and six months ended May 28, 2022 and May 29, 2021 (unaudited)

Notes to Condensed Financial Statements (unaudited)

 

ITEM 2 - MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

ITEM 3 - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

ITEM 4 - CONTROLS AND PROCEDURES

 

 

 

PART II - OTHER INFORMATION

 

ITEM 1 - LEGAL PROCEEDINGS

ITEM 1A -RISK FACTORS

ITEM 2 - UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

ITEM 3 - DEFAULTS UPON SENIOR SECURITIES

ITEM 4 - MINE SAFETY DISCLOSURE

ITEM 5 - OTHER INFORMATION

ITEM 6 - EXHIBITS

 

 

 

SIGNATURES

 

 

 

 

2 
 

 

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

MICROPAC INDUSTRIES, INC.

CONDENSED BALANCE SHEETS

(Dollars in thousands)

   May 28, 2022  November 30, 2021
   (Unaudited)   
       
CURRENT ASSETS          
Cash and cash equivalents  $16,019   $15,252 
Receivables, net of allowance for doubtful accounts of
$0 at May 28, 2022 and November 30, 2021
   3,755    4,974 
Contract assets   725    603 
Inventories:          
       Raw materials and supplies   6,351    5,738 
       Work in process   2,291    2,946 
                             Total inventories   8,642    8,684 
Prepaid expenses and other assets   421    341 
                             Total current assets   29,562    29,854 
           
PROPERTY, PLANT AND EQUIPMENT, at cost:          
Land   1,518    1,518 
Buildings   498    498 
Facility improvements   1,126    1,126 
Furniture and fixtures   1,036    1,025 
Construction in process   16,116    8,019 
Machinery and equipment   9,734    9,390 
                            Total property, plant, and equipment   30,028    21,576 
                            Less accumulated depreciation   (10,886)   (10,739)
                            Net property, plant, and equipment   19,142    10,837 
Operating lease right to use asset   41    67 
                            Total assets  $48,745   $40,758 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
           
CURRENT LIABILITIES:          
Accounts payable  $1,603   $1,963 
Accrued compensation   1,025    1,295 
Deferred revenue   1,174    1,258 
Property taxes   189    318 
Income tax payable   95    180 
Operating lease liabilities, current portion   41    53 
Other accrued liabilities   25    25 
                               Total current liabilities   4,152    5,092 
           
Operating lease liabilities, less current portion         14 
Long Term Debt, net of debt issuance costs   11,613    3,369 
Deferred income taxes, net   16    16 
                               Total liabilities   15,781    8,491 
Commitments and contingencies          
           
SHAREHOLDERS’ EQUITY          
Common stock, $.10 par value, authorized
10,000,000 shares, 3,078,315 issued and
2,578,315 outstanding at May 28, 2022 and
November 30, 2021
   308    308 
Additional paid-in-capital   885    885 
Treasury stock, 500,000 shares, at cost   (1,250)   (1,250)
Retained earnings   33,021    32,324 
                               Total shareholders’ equity   32,964    32,267 
                               Total liabilities and shareholders’ equity  $48,745   $40,758 
           

 

See accompanying notes to financial statements.

  

3 
 

 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF OPERATIONS

(Dollars in thousands except share data)

(Unaudited)

 

                               
        Three Months ended    Six Months Ended
   May 28, 2022  May 29, 2021  May 28, 2022  May 29, 2021
             
             
NET SALES  $7,188   $7,635   $13,254   $11,685 
                     
COST AND EXPENSES:                    
                     
    Cost of goods sold   (4,245)   (4,141)   (7,521)   (6,831)
                     
    Research and development   (502)   (398)   (966)   (743)
                     
    Selling, general and administrative expenses   (1,850)   (1,590)   (3,618)   (2,979)
                     
                                    Total cost and expenses   (6,597)   (6,129)   (12,105)   (10,553)
                     
OPERATING INCOME   591    1,506    1,149    1,132 
                     
Other income (expense), net   1    (3)   2    21 
                     
INCOME BEFORE TAXES   592    1,503    1,151    1,153 
                     
    Provision for taxes   101    210    196    161 
                     
NET INCOME  $491   $1,293   $955   $992 
NET INCOME PER SHARE, BASIC AND DILUTED  $0.19   $0.50   $0.37   $0.38 
                     
DIVIDENDS PER SHARE  $     $     $0.10   $0.10 
                     
WEIGHTED AVERAGE OF SHARES, basic and diluted   2,578,315    2,578,315    2,578,315    2,578,315 
                     

 

See accompanying notes to financial statements.

 

4 
 

 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Dollars in thousands)

(Unaudited)

 

                
   Six months ended
  May 28, 2022  May 29, 2021
 CASH FLOWS FROM OPERATING ACTIVITIES      
Net income  $955   $992 
Adjustments to reconcile net income to net cash provided by (used in) operating activities:          
    Depreciation   197    197 
    Amortization of right-of-use assets   26    23 
    Changes in certain current assets and liabilities:          
        Decrease (increase) in accounts receivable   1,219    (1,080)
        Increase in contract assets   (122)   (394)
        Decrease (increase) in inventories   43    (312)
        Increase (decrease) in prepaid expenses   (80)   86 
        Decrease in prepaid income taxes         223 
        (Decrease) increase in deferred revenue   (84)   106 
        (Decrease) increase in accounts payable   (18)   8 
        Decrease in accrued compensation   (270)   (92)
        Decrease in income tax payable   (85)   (85)
        Decrease in lease liabilities   (26)   (23)
        (Decrease) increase in all other accrued liabilities   (129)   13 
           
        Net cash provided by (used in) operating activities   1,626    (338)
           
CASH FLOWS FROM INVESTING ACTIVITIES          
        Additions to property, plant and equipment   (8,845)   (970)
           
        Net cash used in investing activities   (8,845)   (970)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
         Cash dividend   (258)   (258)
         Proceeds from long term debt   8,244       
           
         Net cash provided by (used in) financing activities   7,986    (258)
           
Net increase (decrease) in cash and cash equivalents   767    (1,566)
           
Cash and cash equivalents at beginning of period   15,252    14,619 
           
Cash and cash equivalents at end of period  $16,019   $13,053 
           
Supplemental Cash Flow Disclosure:          
         Cash paid for income taxes  $257   $24 
Supplemental Non-Cash Flow Disclosure:          
         Changes in accrued property, plant, and equipment  $879   $414 
           

 

See accompanying notes to financial statements.

 

5 
 

 

MICROPAC INDUSTRIES, INC.

CONDENSED STATEMENTS OF SHAREHOLDERS’ EQUITY

FOR THE QUARTERS ENDED MAY 28, 2022 AND MAY 29, 2021

(Dollars in thousands)

(Unaudited)

 

   Common  Additional  Treasury  Retained   
   Stock  paid-in-capital  Stock  Earnings  Total
BALANCE, November 30, 2020  $308   $885   $(1,250)  $29,524   $29,467 
                          
Dividend                     (258)   (258)
Net loss                     (301)   (301)
                          
BALANCE, February 27, 2021  $308   $885   $(1,250)  $28,965   $28,908 
                          
Net income                     1,293    1,293 
                          
BALANCE, May 29, 2021  $308   $885   $(1,250)  $30,258   $30,201 
                          
    Common    Additional     Treasury    Retained      
    Stock       paid-in-capital     Stock    Earnings       Total    
BALANCE, November 30, 2021  $308   $885   $(1,250)  $32,324   $32,267 
                          
Dividend                     (258)   (258)
Net income                     464    464 
                          
BALANCE, February 26, 2022  $308   $885   $(1,250)  $32,530   $32,473 
                          
Net income                     491    491 
                          
BALANCE, May 28, 2022  $308   $885   $(1,250)  $33,021   $32,964 
                          

 

See accompanying notes to financial statements.

 

6 
 

 

MICROPAC INDUSTRIES, INC.

NOTES TO CONDENSED FINANCIAL STATEMENTS

(Unaudited)

 

Note 1 BASIS OF PRESENTATION

 

Business Description

 

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space, medical and commercial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2015 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

 

The Company’s core technology are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

 

The business of the Company was started in 1963 as a sole proprietorship. On March 3, 1969, the Company was incorporated under the name of “Micropac Industries, Inc.” in the state of Delaware. The stock was publicly held by 436 shareholders on May 28, 2022.

 

In the opinion of management, the unaudited financial statements include all adjustments (consisting of only normal, recurring adjustments) necessary to present fairly the financial position as of May 28, 2022, the results of operations for the three and six months May 28, 2022 and May 29, 2021 ant the cash flows for the six months ended May 28, 2022 and May 29, 2021. Unaudited financial statements are prepared on a basis substantially consistent with those audited for the year ended November 30, 2021. Certain information and footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States (GAAP) have been condensed or omitted pursuant to the rules and regulations promulgated by the Securities and Exchange Commission. The Company’s fiscal year ends on the last day of November. The quarterly results end on the last Saturday of the quarter.

 

It is suggested that these financial statements be read in conjunction with the November 30, 2021 Form 10-K filed with the SEC, including the audited financial statements and the accompanying notes thereto.

 

Note 2 SIGNIFICANT ACCOUNTING POLICIES

 

Revenue Recognition

 

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.

 

The Company's revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products.

 

To achieve that core principle, the Company applies the following steps:

 

1.Identify the contract(s) with a customer.

 

The Company designs, manufactures and distributes various types of microelectronic circuits, optoelectronics, and sensors and displays. The Company’s products are used as components and assemblies in a broad range of military, space, medical and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

7 
 

The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.

 

2.Identify the performance obligations in the contract.

 

The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.

 

3.Determine the transaction price.

 

The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.

 

4.Allocate the transaction price to the performance obligations in the contract.

 

The Company’s transaction price is the fixed price per unit per each delivery upon shipment.

 

5.Recognize revenue when (or as) the Company satisfies a performance obligation.

 

This performance obligation is satisfied when control of the product is transferred to the customer, which occurs upon shipment or delivery. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each delivery upon shipment and recognizes revenues at the fixed price for each distinct product delivered when transfer of control has occurred, which is generally upon shipment.

 

For certain contracts under which the Company produces products with no alternative use and for which the Company has an enforceable right to payment during the production cycle, the Company recognizes revenue for the cost incurred of work in process plus a margin at the end of each period and records a contract asset (unbilled receivable). The majority of these products are shipped weekly and monthly to the customers and the contracts require us to manage and limit the level of work in process to meet the scheduled delivery dates.

 

In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed, and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.

 

Disaggregation of Revenue

The following table summarizes the Company’s Net Sales by Product Line.

     5/28/2022     5/29/2021
Microcircuits  $3,400  $2,741
Optoeletronics   4,235   3,774
Sensors and Displays   5,619   5,170
    Total Revenue  $13,254  $11,685
         
Timing of revenue recognition        
Transferred at a point in time  $11,429  $9,770
Transferred over time   1,825   1,915
    Total Revenue  $13,254  $11,685

 

8 
 

 

The following table summarizes the Company’s Net Sales by Major Market.

                                         

2022 Second Quarter Sales by Major Market

   Military  Space  Medical  Commercial  Total
Domestic Direct  $3,134   $196   $830   $344   $4,504 
Domestic Distribution   1,591    572    0    334    2,497 
International         127    0    60    187 
   $4,725   $895   $830   $738   $7,188 
                          
2021 Second Quarter Sales by Major Market
     Military      Space      Medical      Commercial      Total  
Domestic Direct  $2,588   $951   $1,158   $139   $4,836 
Domestic Distribution   2,308    172    0    178    2,658 
International   64    9    0    68    141 
   $4,960   $1,132   $1,158   $385   $7,635 
                          
 2022 Six Months Sales by Major Market
     Military      Space      Medical      Commercial      Total  
Domestic Direct  $5,638   $799   $1,384   $534   $8,355 
Domestic Distribution   3,384    718          473    4,575 
International   71    150          103    324 
   $9,093   $1,667   $1,384   $1,110   $13,254 
                          
  2021 Six Months Sales by Major Market
     Military      Space      Medical      Commercial      Total  
Domestic Direct  $4,011   $1,170   $1,708   $287   $7,176 
Domestic Distribution   3,335    536          297    4,168 
International   127    136          78    341 
   $7,473   $1,842   $1,708   $662   $11,685 

 

 

Receivables, net, Contract Assets and Contract Liabilities

 

The timing of revenue recognition, billings and cash collections results in billed accounts receivable, unbilled receivables (contract assets), and customer advances and deposits (deferred revenue) on the Condensed Balance Sheet. 

 

Receivables, net, contract assets and contract liabilities were as follows:

 

Receivables, net, Contract Assets and Contract Liabilities

(Dollars in thousands)

 

  May 28, 2022  November 30, 2021  December 1, 2020
Receivables, net $3,755   $4,974   $2,639 
Contract assets $725   $603   $512 
Deferred revenue $1,174   $1,258   $111 

 

There was $103,000 of revenue recognized in fiscal year 2022 that was included in the deferred revenue liability balance at the beginning of the fiscal year.

 

Contract costs

 

The Company does not have material incremental costs to obtain a contract in the form of sales commissions or bonuses. The Company incurs other immaterial costs to obtain and fulfill a contract; however, the Company has elected the practical expedient under ASC 340-40-24-4 to recognize all incremental costs to obtain a contract as an expense when incurred if the amortization period is one year or less.

 

Leases

 

In the first quarter of 2020, the Company entered into a three (3) year lease extension on the property that has been leased on a year to year basis. As a result, we recognized $165,000 for operating lease liabilities and right-of-use assets in accordance with ASC 842. The Company had an operating lease expense of $26,000 for the first six months of 2022 and $26,000 for the first six months of 2021. The Company used an estimated incremental borrowing rate of 3.25% representative of the rate of interest that the company would have to pay to borrow on the Company’s line of credit. The remaining lease term is three years.

9 
 

 

The Undiscounted Future Minimum Lease Payments consist of the following at:

     5/28/2022  
2022   $28,000 
2023    14,000 
Total lease payments    42,000 
Interest    1,000 
Present value of lease liabilities   $41,000 
       

 

Short-Term Investments

 

The Company had no short-term investments at May 28, 2022 or November 30, 2021. Short-term investments consist of certificates of deposits with maturities greater than 90 days. These investments are reported at historical cost, which approximates fair value. All highly liquid investments with maturities of 90 days or less are classified as cash equivalents.

 

Inventories

 

Inventories are stated at lower of cost or net realizable value and include material, labor and manufacturing overhead. All inventories are valued using the FIFO (first-in, first-out) method of inventory valuation. The Company determines the need to write inventory down to the lower of cost or net realizable value via an analysis based on the usage of inventory over a three year period and projected usage based on current backlog.

 

Income Taxes

 

The Company accounts for income taxes using the asset and liability method. Under this method the Company records deferred income taxes for the temporary differences between the financial reporting basis and the tax basis of assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled. The resulting deferred tax liabilities and assets are adjusted to reflect changes in tax law or rates in the period that includes the enactment date.

 

The Company records a liability for an unrecognized tax benefit for a tax position that is not “more-likely-than-not” to be sustained.  The Company did not record any liability for uncertain tax positions as of May 28, 2022 or November 30, 2021.

 

Property, Plant, and Equipment

 

Property, plant, and equipment are carried at cost, and depreciation is provided using the straight-line method at rates based upon the following estimated useful lives (in years) of the assets:

 

       
Buildings ......................................................................................................................................................... 15 30
Facility improvements ......................................................................................................................................................... 8 15
Machinery and equipment ......................................................................................................................................................... 5 10
Furniture and fixtures ......................................................................................................................................................... 5 8

 

The Company assesses long-lived assets for impairment in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) ASC 360-10-35, Property, Plant and Equipment – Subsequent Measurement. When events or circumstances indicate that an asset may be impaired, an assessment is performed. The estimated future undiscounted cash flows associated with the asset are compared to the asset’s net book value to determine if a write down to market value less cost to sell is required.

 

Construction in progress relates to multiple capital projects ongoing during the years ended November 30, 2021 and the six months ended May 28, 2022, including the construction of the new manufacturing facility. Construction in progress also includes interest and fees on debt that are directly related to the financing of the Company’s capital projects.

 

Repairs and maintenance are expensed as incurred. Improvements which extend the useful lives of property, plant, and equipment are capitalized.

 

Research and Development Costs

 

Costs for the design and development of new products are expensed as incurred.

 

Basic and Diluted Earnings Per Share

 

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common

10 
 

shares. For the three months and six months ended May 28, 2022 and May 29, 2021, the Company had no dilutive potential common stock instruments.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

 

Note 3 NEW ACCOUNTING PRONOUNCEMENTS

 

In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which changes the impairment model for most financial assets. The ASU requires the use of an “expected loss” model for instruments measured at amortized cost, in which companies will be required to estimate the lifetime expected credit loss and record an allowance to offset the amortized cost basis, resulting in a net presentation of the amount expected to be collected on the financial asset. The new guidance is effective for fiscal years beginning after December 15, 2022 for Smaller Reporting Companies, including interim periods within those fiscal years and requires a modified-retrospective approach to adoption. The Company believes that adopting ASU 2016-13 will have no material impact on the financial statements and related disclosures.

 

Note 4 FAIR VALUE MEASUREMENT

 

The Company had no financial assets or liabilities measured at fair value on a recurring basis as of May 28, 2022 or November 30, 2021.  The fair value of financial instruments such as cash and cash equivalents, accounts receivable, and accounts payable approximate their carrying amount based on the short maturity of these instruments.

 

The Company measures its long-term debt at fair value, which approximates book value as the long-term debt bears market rates of interest

 

There were no nonfinancial assets measured at fair value on a nonrecurring basis May 28, 2022 and November 30, 2021.

 

Note 5 COMMITMENTS

 

The Company obtained a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas that the Company has purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement (the “loan agreement”) with Frost Bank (“Frost”) (acting as lender). The Construction Loan Agreement provides for a construction loan, in amounts not to exceed a total principal balance of $16,160,000 with an interest rate of (3.40%) per annum.

 

On March 26, 2021, the Company renewed the Revolving Loan Agreement with Frost through the “Sixth Amendment to Loan Agreement.”. The Revolving Loan Agreement provides for revolving credit loans, in amounts not to exceed a total principal balance of $6,000,000 with a rate equal to prime rate with a floor of 3.25%. The Revolving Loan Agreement was originally entered into on January 23, 2013, between the Company as borrower and Frost as lender.  

 

Construction Loans.  Subject to the terms of the Loan Agreement, Frost will lend to the Company an aggregate amount not to exceed $16,160,000.

 

Principal and interest shall be due and payable monthly in an amounts determined by Lender required to fully amortize the outstanding principal balance of this Note over a period of twenty-five (25) years, payable on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2023, and continuing regularly thereafter until March 26, 2031, when the entire amount hereof, principal and accrued interest then remaining unpaid, shall be then due and payable; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

 

The interest rate of (3.40%) per annum including an Interest-Only Period. Interest only shall be due and payable monthly as it accrues on the twenty-sixth (26th) day of each and every calendar month, beginning April 26, 2021, and continuing regularly and monthly thereafter until March 26, 2023; interest being calculated on the unpaid principal each day principal is outstanding and all payments made credited to any collection costs and late charges, to the discharge of the interest accrued and to the reduction of the principal, in such order as Lender shall determine.

11 
 

The loan shall be secured by a “Deed of Trust, Security Agreement – Financing Statement” covering the 9.2 acre tract in Garland, Texas and the improvements made on it.

 

Revolving Credit Loans.  Subject to the terms of the, Loan Agreement, Frost will lend to the Company, on a revolving basis, amounts not to exceed a total principal balance of $6,000,000, minus amounts available and amounts previously disbursed under outstanding Frost letters of credit. Subject to certain terms and conditions, the Company may borrow, repay and reborrow under the Loan Agreement. The loan has a maturity date of April 23, 2023.

 

The interest on the outstanding and unpaid principal balance shall be computed at a per annum rate equal to the lesser of (a) a rate equal to the Prime Rate per annum; provided, however, in no event shall the resulting rate be less than three and one-quarter percent (3.25%).

 

The Company has borrowed $11,792,000 against the construction loan as of May 28, 2022. 

 

Debt    May 28, 2022  
Notes payable  $11,792,000 
Less unamortized debt issuance costs   179,000 
Net Debt   11,613,000 
Less—Current portion      
Total long-term debt  $11,613,000 

 

Note 6 EARNINGS PER COMMON SHARE

 

Basic and diluted earnings per share are computed based upon the weighted average number of shares outstanding during the respective periods. Diluted earnings per share gives effect to all dilutive potential common shares. For the three and six month periods ended May 28, 2022 and May 29, 2021, the Company had no dilutive potential common stock instruments.

 

Note 7 SHAREHOLDERS’ EQUITY

 

On December 8, 2020, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 6, 2021. The dividend was paid to shareholders on February 12, 2021.

 

On December 7, 2021, the Board of Directors of Micropac Industries, Inc. approved the payment of a $0.10 per share special dividend to all shareholders of record as of January 11, 2022. The dividend was paid to shareholders on February 10, 2022.

 

 

[The remainder of this page intentionally left blank.]

12 
 

 

MICROPAC INDUSTRIES, INC.

(Unaudited)

 

 

ITEM 2.MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Business

 

Micropac Industries, Inc. (the “Company”), a Delaware corporation, designs, manufactures and distributes various types of microelectronic circuits including solid state relays and power controllers, optoelectronic components, and sensor and display components and assemblies. The Company’s products are used as components and assemblies in a broad range of military, space and industrial systems, including aircraft instrumentation and navigation systems, satellite systems, power supplies, electronic controls, computers, medical devices, and high-temperature (200o C) products.

 

The Company’s facilities are certified and qualified by the Defense Logistics Agency (DLA) to MIL-PRF-38534 (class K-space level) and MIL-PRF-19500 JANS (space level) and are certified to ISO 9001:2008 and AS 9100D. Micropac is a National Aeronautics and Space Administration (NASA) core supplier, and is registered to AS9100-Aerospace Industry standard for supplier certification. The Company has Underwriters Laboratories (UL) approval on our industrial power controllers.

 

The Company’s core technology are microelectronic and optoelectronic designs to include the packaging and interconnecting of multi-chip microelectronics modules. Other technologies include light emitting and light sensitive materials and products, including light emitting diodes and silicon phototransistors, and electronic integration used in the Company’s optoelectronic components and assemblies.

 

Critical Accounting Policies

 

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. We base our estimates on historical experience and on various other assumptions and factors that are believed to be reasonable under the circumstances. Note 2 to the Financial Statements in the Quarterly Report Form 10-Q for the quarter ended May 28, 2022, describes the significant accounting policies and methods used in the preparation of the Financial Statements. liabilities. Actual results could differ from these estimates.

 

The core principle of revenue recognition under accounting principles generally accepted in the Unites States of America (GAAP) is that the Company should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The Company’s revenue on the majority of its customer contracts are recognized at a point in time, generally upon shipment of products. The application of GAAP related to the measurement and recognition of revenue requires us to make judgments and estimates. Specifically, the determination of whether revenues related to our revenue contracts should be recognized over time or at a point in time, as these determinations impact the timing and amount of our reported revenues and net income. Other significant judgments include the estimation of the point in the manufacturing process at which we are entitled to receive payment, as well as the progress of the job order to completion in order to determine the amount of consideration earned for contractual revenue recognized over time.

 

The allowance for doubtful accounts is based on our assessment of the collectability of specific customer accounts and the aging of the accounts receivable. If there is a deterioration of a major customer’s credit worthiness or actual defaults are higher than our historical experience, our estimates of the recoverability of amounts due us could be adversely affected.

 

Inventory purchases and commitments are based upon future demand. If there is a sudden and significant decrease in demand for our products or there is a higher risk of inventory obsolescence because of changing customer requirements, we may be required to increase our inventory allowances and our gross margin could be adversely affected.

 

The Company recognizes deferred tax assets and liabilities based on differences between the financial reporting and tax basis of assets and liabilities using the enacted tax rates and laws that are expected to be in effect when the differences are expected to be recovered. If we were to determine we would not be able to realize all or part of the deferred tax asset in the future, an adjustment to the deferred tax asset would be necessary which would reduce our net income for that period.

 

Depreciable and useful lives estimated for property and equipment are based on initial expectations of the period of time these assets will provide benefit. Changes in circumstances related to a change in our business

13 
 

or other factors could result in these assets becoming impaired, which could adversely affect the value of these assets.

 

Results of Operations

       Three months ended  Six months ended
    5/28/2022    5/29/2021    5/28/2022    5/29/2021 
NET SALES   100.0%   100.0%   100.0%   100.0%
                     
COST AND EXPENSES:                    
    Cost of Goods Sold   59.1%   54.3%   56.7%   58.4%
    Research and development   7.0%   5.2%   7.3%   6.4%
    Selling, general and administrative expenses   25.7%   20.8%   27.3%   25.5%
                                    Total cost and expenses   91.8%   80.3%   91.3%   90.3%
                     
OPERATING INCOME BEFORE INTEREST   8.2%   19.7%   8.7%   9.7%
           AND INCOME TAXES                    
                     
    Interest and other income, net   —      —      —      0.2%
                     
INCOME BEFORE TAXES   8.2%   19.7%   8.7%   9.9%
                     
    Provision for taxes   1.4%   2.8%   1.5%   1.4%
                     
NET INCOME   6.8%   16.9%   7.2%   8.5%

 

 

Sales for the three and six month periods ended May 28, 2022 totaled $7,188,000 and $13,254,000, respectively. Sales for the second quarter decreased $447,000 from the same period of 2021 while sales for the first six months of 2022 increased $1,569,000 from the first six months of 2021. The majority of the increase is related to timing of shipments of customer orders of standard microelectronic products. Sales were 8% in the commercial market, 10% in the medical market, 69% in the military market, and 13% in the space market for the six months ended May 28, 2022 compared to 6% in the commercial market, 14% in the medical market, 64% in the military market, and 16% in the space market for the six months ended May 29, 2021.

 

Two customers accounted for 15% and 11% of the Company’s sales for the three months ended May 28, 2022, and one customer accounted for 17% for the six months ended May 28, 2022, while one customer accounted for 20% and 19% of the Company’s sales for the three months and six months ended May 29, 2021.

 

Cost of goods sold for the second quarters of 2022 and 2021 totaled 59.1% and 54.3% of net sales, respectively, while cost of goods sold for the six months ended May 28, 2022 and May 29, 2021 totaled 56.7% and 58.4% of net sales, respectively. In actual dollars, cost of goods sold increased $104,000 in the second quarter of 2022 compared to the same period of 2021. Year to date cost of goods sold increased $690,000 for the first six months of 2022 as compared to the same period in 2021. The majority of the increase in the second quarter is associated with the increase in cost of goods sold with the decrease in sales compared to second quarter of 2021.

 

Research and development expense increased $104,000 for the second quarter of 2022 versus 2021 and increased $223,000 for the first six months of 2022 compared to the same period of 2021. The research and development expenditures were associated with continued development of several power management products, fiber optic transceivers and high voltage optocouplers. The Company will continue to invest in research and development of these products and other new opportunities.

 

Selling, general and administrative expenses for the second quarter and first six months of 2022 totaled 25.7% and 27.3% respectively of net sales compared to 20.8% and 25.5% for the same periods in 2021. In actual dollars, selling, general and administrative expenses increased $260,000 for the second quarter and increased $639,000 for the first six months of 2022 compared to the same periods in 2021. The majority of the increase for the first six months resulted from an increase in commission expense in 2022, property tax on the new building and consultant fees.

 

14 
 

Provisions for taxes decreased $109,000 for the second quarter of 2022 and increased $35,000 for the first six months of 2022 compared to the same period in 2021. The estimated effective tax rate was 17% for 2022 and 14% for 2021.

 

Net income decreased $802,000 for the second quarter of 2022 versus 2021 and decreased $36,000 for the first six months of 2022 compared to the same period of 2021.

 

Liquidity and Capital Resources

 

The Company will use a combination of cash and a commercial real estate construction loan for the construction of a new 76,000 square foot manufacturing center on the 9.2 acres of land in Garland, Texas the Company purchased. On March 26, 2021, the Company (acting as borrower) entered into a Construction Loan Agreement with Frost Bank (“Frost”), (acting as lender). The Construction Loan Agreement provides for a construction loan as discussed in Note 5 to the condensed financial statements.

 

As of May 28, 2022, the Company has $16,116,000 in construction in process on the new facility and has $11,792,000 in notes payable on the construction loan, outstanding draw request of $879,000 in accounts payable and has used $2,515,000 of the Company’s cash. In addition, the Company has unamortized loan fees on the construction loan in the amount of $179,000.

In addition, the Company continues on-going investigations for the use of cumulative cash for business expansion and improvements, such as operational improvements and new product expansion.

 

Cash and cash equivalents totaled $16,019,000 as of May 28, 2022 compared to $15,252,000 on November 30, 2021, an increase of $767,000. The increase in cash and cash equivalents is attributable to $1,626,000 cash provided by operations, $8,244,000 proceeds from the construction loan, offset by the payment of a cash dividend of $258,000, $356,000 in cash for additional manufacturing equipment and $8,489,000 for construction in process on the new facility.

 

In addition to cash on hand, the Company also has the ability to borrow under a loan agreement as discussed in Note 5 to the condensed financial statements.

 

The Company has no significant off-balance sheet arrangements.

 

Outlook

 

New orders for year-to-date 2022 totaled $15,395,000 compared to $13,105,000 for 2021. The increase resulted from timing of new orders for several custom products.

 

Backlog totaled $35,055,000 on May 28, 2022 compared to $31,517,000 as of May 29, 2021 and $32,635,000 on November 30, 2021 and represents a good mix of the company’s products and technologies.

 

2022 Current Backlog by Major Market
   Military  Space  Medical  Commercial  Total
Domestic Direct  $17,937   $1,359   $4,263   $2,312   $25,871 
Domestic Distribution   7,594    710    —      430    8,734 
International   116    65    —      269    450 
   $25,647   $2,134   $4,263   $3,011   $35,055 

 

2022 Current Backlog by Product Line
Microelectronics  $12,507 
Optoelectronics   5,639 
Sensors and Displays   16,909 
   $35,055 

 

 

The Company cannot assure that the results of operations for the interim period presented are indicative of total results for the entire year due to fluctuations in customer delivery schedules, or other factors over which the Company has no control.

 

Impact of COVID-19 on our Business

 

In March 2020 the World Health Organization declared the spread of the COVID-19 virus a pandemic.

15 
 

 

The Company continues to monitor our supply chain and orders from customers for COVID-19 pandemic related changes. We are continuing to serve our customers while taking precautions to provide a safe work environment for our employees and customers. We have been staggering some shifts and otherwise adjusting work schedules to maximize our capacity while adhering to recommended precautions. We have established and implemented a work from home provision where possible.

 

To date, we have not experienced significant raw material shortages; however, supply-chain disruptions could potentially delay or prevent us from fulfilling customer orders.

 

Cautionary Statement

 

This Form 10-Q contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially. Investors are warned that forward-looking statements involve risks and unknown factors including, but not limited to: our expectations regarding the potential impacts on our operations of the COVID-19 pandemic; our expectations regarding the potential impacts on our supply chain and on our customers of the COVID-19 pandemic; overall changes in governmental spending for military and space programs; customer cancellation or rescheduling of orders, problems affecting delivery of vendor-supplied raw materials and components, unanticipated manufacturing problems and availability of direct labor resources.

 

The Company does not intend to update the forward-looking statements contained herein, except as may be required by law.

 

ITEM 3.QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable

 

ITEM 4.CONTROLS AND PROCEDURES

 

(a)Evaluation of disclosure controls and procedures.

 

The Chief Executive Officer and Chief Financial Officer of the Company evaluated the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15) as of May 28, 2022 and, based on this evaluation, concluded that the Company’s disclosure controls and procedures are functioning in an effective manner to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms.

 

(b)Changes in internal controls.

 

There has been no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting during the three month period ended May 28, 2022.

 

PART II - OTHER INFORMATION

 

ITEM 1.LEGAL PROCEEDINGS

 

The Company is not involved in any material current or pending legal proceedings.

 

ITEM 1ARISK FACTORS

 

Information about risk factors for the three and six months ended May 28, 2022 does not differ materially from that set forth in Part I, Item 1A, of our Annual Report on Form 10-K for the year ended November 30, 2021

 

ITEM 2.UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

None

 

ITEM 3.DEFAULTS UPON SENIOR SECURITIES

 

None

 

ITEM 4.

MINE SAFETY DISCLOSURE 

  

16 
 

Not Applicable

 

ITEM 5.

OTHER INFORMATION 

 

None

 

ITEM 6.

EXHIBITS 

 

(a)        Exhibits

 

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Accounting Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Executive Officer pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

32.2

Certification of Chief Accounting Officer pursuant to 18 U. S. C. section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley act of 2002.

   

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned duly authorized.

 

 

 

MICROPAC INDUSTRIES, INC.

 

 

 

 

July 12, 2022   /s/ Mark King
Date   Mark King
    Chief Executive Officer

 

July 12, 2022   /s/ Patrick Cefalu
Date   Patrick Cefalu
    Chief Financial Officer